Freedom of Information

Title
Drug Patient Level Contract Monitoring and SACT reports
Reference Number
RF23-221
Request Details

I would be grateful if you could send me two datasets from your Trust, to inform this analysis:
(1) SACT Cancer report
An extract from the chemotherapy ePMA system showing patients treated by drug and diagnosis, as specified in table 1 (below).
(2) Drug Patient Level Contract Monitoring (DrPLCM) report
Data fields from the DrPLCM report, as specified in table 2 (below). Please do not send patient IDs or cost data, as I appreciate this would compromise data privacy and commercial sensitivity.

Please email your response by reply with the data in .csv format : as the requester has asked for a .CSV we have to provide it as such under the FOI Act.

Appendices – specifications
Please include the data fields specified within table 1 and table 2:

(1) Table 1 - SACT Cancer report
An extract of records from the chemotherapy ePMA system Dec 2022 and Mar 2023 for all solid tumour and haematology malignancies (ICD-10 primary diagnosis codes C* and D*)
Source: NHS Digital, NHS Data Model and Dictionary, Systemic Anti-cancer Therapy Data Set https://www.datadictionary.nhs.uk/data_sets/clinical_data_sets/systemic_anti-cancer_therapy_data_set.html
Organisation code (code of provider)
Organisation identifier (of SACT administration)
Primary diagnosis (ICD-10 3rd or 4th digit)
Morphology (ICD-O)
TNM stage
Adjunctive therapy type
Regimen treatment intent
Drug Regimen
Clinical trial indicator
Drug name
Actual dose
Unit of measure
Route of administration
Cycle number
Number of planned cycles
SACT administration date

(2) Table 2 - Drug Patient Level Contract Monitoring (DrPLCM) report
An extract of records from this report for all hospitals in the Trust for the three months between Jan 2023 and Mar 2023
Sourced from NHS Digital, DrPLCM Technical Specification V2.6 document
https://digital.nhs.uk/data-and-information/information-standards/information-standards-and-data-collections-including-extractions/publications-and-notifications/standards-and-collections/contract-monitoring

Field number Data Element
1 FINANCIAL MONTH
2 FINANCIAL YEAR
5 ORGANISATION IDENTIFIER (CODE OF PROVIDER)
6 ORGANISATION SITE IDENTIFIER (OF TREATMENT)
9 ORGANISATION IDENTIFIER (CODE OF COMMISSIONER)
19 ACTIVITY TREATMENT FUNCTION CODE
22 CLINICAL INTERVENTION DATE (DRUG DISPENSED)
23 THERAPEUTIC INDICATION CODE (SNOMED CT)
26 DRUG NAME (HIGH COST TARIFF EXCLUDED DRUG)
27 ROUTE OF ADMINISTRATION (SNOMED CT DM+D)
28 DRUG STRENGTH (HIGH COST TARIFF EXCLUDED DRUG)
29 DRUG VOLUME (HIGH COST TARIFF EXCLUDED DRUG)
30 DRUG PACK SIZE (HIGH COST TARIFF EXCLUDED DRUG)
31 DRUG QUANTITY OR WEIGHT PROPORTION (HIGH COST TARIFF EXCLUDED DRUG)
32 UNIT OF MEASUREMENT (SNOMED CT DM+D)
33 DISPENSING ROUTE (HIGH COST TARIFF EXCLUDED DRUG)
34 PROVIDER REFERENCE NUMBER
35 COMMISSIONED SERVICE CATEGORY CODE
36 SERVICE CODE
37 NATIONAL CANCER DRUGS FUND FORM CODE
44 LOCAL CONTRACT MONITORING CODE
45 LOCAL CONTRACT MONITORING DESCRIPTION
46 CONTRACT MONITORING ADDITIONAL DETAIL (FIRST)
47 CONTRACT MONITORING ADDITIONAL DESCRIPTION (FIRST)
51 VALUE ADDED TAX CHARGED INDICATOR (CONTRACT MONITORING)

Response
  • rf23-221-response.pdf
  • Date of Disclosure
    04/12/2023